Medicinal product name Bortezomib Stada 2.5 mg/ml solution for injection
Pharmaceutical form Solution for injection
Strength 2.5 mg/ml 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Package leafletPDF 03-11-2022
Summary of product characteristicsMS Word document 19-05-2022
ATC code L01XG01 Antineoplastic agents
Information for Marketing authorisation holdersView

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(3,5 mg/1,4 ml)
Glass vial    21-0020-01 Labelling text Labelling text May 19, 2022
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(7 mg/2,8 ml)
Glass vial    21-0020-02 Labelling text Labelling text May 19, 2022

Registration information

Marketing authorisation No. 21-0020
Date of authorisation Feb 8, 2021
Marketing authorisation holder, country Stada Arzneimittel AG, Germany